Patent · US Active

Antibodies, combinations comprising antibodies, biomarkers, uses and methods

US11779604B2 · kind B2 · utility

0Cited by
131References
4Claims
0Family size

Assignee

Inventors

Key dates

Filing dateNov 3, 2017
Grant dateOct 10, 2023
Priority date
Expiry dateNov 3, 2037

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07K2319/32
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The present invention relates to combinations comprising anti-human x OX40L antibodies, new biomarkers of autoimmune or alloimmune deseases, and their use in various therapeutic methods.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.